الأبحاث والداراسات التي إستندت فيها في الفيديو ,أتمنى منكم التعليق ونشر القناة ودعمها للإستمرار في تقديم المحتوى العلمي اللائق بكم REFERENCES : New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease https://pubmed.ncbi.nlm.nih.gov/24428677/ Selective Androgen Receptor Modulators (SARMs) as Function Promoting Therapies https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907129/ PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2393796/ The PPARβ/δ Agonist GW501516 Attenuates Peritonitis in Peritoneal Fibrosis via Inhibition of TAK1–NFκB Pathway in Rats https://link.springer.com/article/10.1007/s10753-013-9791-z Lipid effects of peroxisome proliferator-activated receptor-δ agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndrome The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells https://link.springer.com/article/10.1007/s00125-011-2401-4 Activation of PPARβ/δ Induces Endothelial Cell Proliferation and Angiogenesis https://www.ahajournals.org/doi/full/10.1161/01.atv.0000250972.83623.61 Early controlled release of peroxisome proliferator-activated receptor β/δ agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment https://www.sciencedirect.com/science/article/abs/pii/S0168365914007354?np=y https://pubmed.ncbi.nlm.nih.gov/22814748/ The PPARβ/δ Agonist GW501516 Attenuates Peritonitis in Peritoneal Fibrosis via Inhibition of TAK1–NFκB Pathway in Rats Lipid effects of peroxisome proliferator-activated receptor-δ agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndrome https://link.springer.com/article/10.1007/s10753-013-9791-z Pharmacological targeting of exercise adaptations in skeletal muscle: Benefits and pitfalls https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850978/ Effects of the PPAR-beta agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination https://pubmed.ncbi.nlm.nih.gov/19422681/ The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells https://link.springer.com/article/10.1007/s00125-011-2401-4 A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport https://www.pnas.org/doi/full/10.1073/pnas.091021198 Angiogenesis in cancer, vascular, rheumatoid and other disease https://pubmed.ncbi.nlm.nih.gov/7584949/ GW501516, a PPARδ Agonist, Ameliorates Tubulointerstitial Inflammation in Proteinuric Kidney Disease via Inhibition of TAK1-NFκB Pathway in Mice https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178624/ Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361396/ Effect of PPARβ/δ Agonist on the Placentation and Embryo-Fetal Development in Rats https://onlinelibrary.wiley.com/doi/abs/10.1002/bdrb.21052 New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease https://pubmed.ncbi.nlm.nih.gov/24428677/ The Role of PPARs in Cancer https://www.hindawi.com/journals/ppar/2008/102737/ Regulation of epithelial–mesenchymal IL-1 signaling by PPARβ/δ is essential for skin homeostasis and wound healing https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699156/ The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1 https://www.sciencedirect.com/science/article/abs/pii/S0006295210008452 🔹Mohammed Rashad gharibeh MBBS ,MD,MEd,IES ▪️MBBS,Reproductive Endocrinology/Infertility Residency program ▫️AMERICAN BOARD OF INTERNAL MEDICINE IN ENDOCRINOLOGY,DIABETES & METABOLISM ▪️EUROPEAN BOARD UEMS IN ENDOCRINOLOGY,DIABETES AND METABOLISM ▫️MEd (master of education) -Cincinnati ▪️Senior Lecturer in Sport Science,Anatomy and Exercise Physiology ▫️IES - Innovative Education Specialist ▪️Weight Management and body Reshape specialist 🔴ملاحظة هامة🔴 هذه القناة وصاحبها لا تشجع على استخدام محسنات الاداء الرياضي (الانابوليك ستيرويد) بل تسعى الى توعية الشباب من اضرارها واضرار الاستخدام الخاطئ لمن قرروا بمحض ارادتهم استخدام محسنات الاداء الرياضي دون استشارتي سابقاً،ولا تعد هذه القناة بحال من الاحوال تشجيعاً على استخدام اي منها لما لها من اضرار خطيرة في بعض الحالات،